Martin J Gepsman insider trades: Cme Group (CME) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Martin reports to the SEC
Open-market buys and sales
33 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 22, 2026 | CME | ↓ Sell | 400 | $302.50 | $121K | Direct | Oct 22, 2026 (0d) |
| Feb 20, 2026 | CME | ↓ Sell | 300 | $305.90 | $92K | Direct | Feb 20, 2026 (0d) |
| May 15, 2025 | CME | ↓ Sell | 300 | $273.17 | $82K | Direct | May 19, 2025 (4d) |
| Nov 4, 2024 | CME | ↓ Sell | 400 | $222.92 | $89K | Direct | Nov 4, 2024 (0d) |
| Oct 26, 2023 | CME | ↓ Sell | 300 | $216.33 | $65K | Direct | Oct 26, 2023 (0d) |
| Dec 7, 2021 | CME | ↓ Sell | 500 | $231.00 | $116K | Direct | Dec 9, 2021 (2d) |
| Oct 28, 2021 | CME | ↓ Sell | 500 | $218.26 | $109K | Direct | Oct 28, 2021 (0d) |
| Sep 13, 2021 | CME | ↓ Sell | 1,000 | $188.53 | $189K | Direct | Sep 13, 2021 (0d) |
| Sep 7, 2021 | CME | ↓ Sell | 1,000 | $194.25 | $194K | Direct | Sep 8, 2021 (1d) |
| Aug 30, 2021 | CME | ↓ Sell | 1,000 | $201.00 | $201K | Direct | Aug 30, 2021 (0d) |
| Aug 23, 2021 | CME | ↓ Sell | 1,000 | $201.37 | $201K | Direct | Aug 23, 2021 (0d) |
| Mar 11, 2021 | CME | ↓ Sell | 1,500 | $205.46 | $308K | Direct | Mar 12, 2021 (1d) |
| Dec 14, 2020 | CME | ↓ Sell | 400 | $178.44 | $71K | Direct | Dec 15, 2020 (1d) |
| Dec 1, 2020 | CME | ↓ Sell | 800 | $178.60 | $143K | Direct | Dec 2, 2020 (1d) |
| Sep 2, 2020 | CME | ↓ Sell | 5,000 | $173.52 | $868K | Direct | Sep 3, 2020 (1d) |
| Jan 3, 2020 | CME | ↓ Sell | 1,000 | $201.16 | $201K | Direct | Jan 7, 2020 (4d) |
| Jun 6, 2019 | CME | ↓ Sell | 2,500 | $201.21 | $503K | Direct | Jun 10, 2019 (4d) |
| May 7, 2019 | CME | ↓ Sell | 2,000 | $178.07 | $356K | Direct | May 9, 2019 (2d) |
| Mar 14, 2019 | CME | ↓ Sell | 3,000 | $167.91 | $504K | Direct | Mar 18, 2019 (4d) |
| Sep 13, 2018 | CME | ↓ Sell | 300 | $172.30 | $52K | Direct | Sep 14, 2018 (1d) |
| May 25, 2018 | CME | ↓ Sell | 600 | $159.77 | $96K | Direct | May 29, 2018 (4d) |
| Feb 15, 2018 | CME | ↓ Sell | 300 | $164.29 | $49K | Direct | Feb 16, 2018 (1d) |
| Aug 9, 2017 | CME | ↓ Sell | 200 | $126.14 | $25K | Direct | Aug 11, 2017 (2d) |
| Sep 2, 2016 | CME | ↓ Sell | 300 | $109.00 | $33K | Direct | Sep 2, 2016 (0d) |
| Jul 29, 2016 | CME | ↓ Sell | 500 | $102.60 | $51K | Direct | Aug 2, 2016 (4d) |
| Aug 13, 2015 | CME | ↓ Sell | 700 | $96.93 | $68K | Direct | Aug 14, 2015 (1d) |
| Mar 3, 2015 | CME | ↓ Sell | 500 | $96.65 | $48K | Direct | Mar 5, 2015 (2d) |
| Nov 14, 2014 | CME | ↓ Sell | 500 | $84.78 | $42K | Direct | Nov 17, 2014 (3d) |
| Aug 1, 2014 | CME | ↓ Sell | 800 | $74.46 | $60K | Direct | Aug 1, 2014 (0d) |
| Nov 18, 2013 | CME | ↓ Sell | 500 | $79.54 | $40K | Direct | Nov 20, 2013 (2d) |
| May 6, 2013 | CME | ↓ Sell | 500 | $61.04 | $31K | Direct | May 7, 2013 (1d) |
| Nov 4, 2009 | CME | ↓ Sell | 200 | $296.13 | $59K | Direct | Nov 6, 2009 (2d) |
| Aug 31, 2009 | CME | ↓ Sell | 200 | $290.86 | $58K | Direct | Sep 9, 2009 (9d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CME insiders
Open-market trades in the last 12 months
About Martin J Gepsman's insider trades
Martin J Gepsman is a director at Cme Group (CME). Since Aug 31, 2009, Martin has reported no open-market purchases and 33 sales worth $5.1M on SEC Form 4. In the last 12 months: 2 sales ($213K).
Their filings also include grants and awards (26 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CME insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.